Direxion Daily TSLA Bull 1.5X Shares

ProShares UltraShort Bloomberg Natrl Gas

GraniteShares 1.5x Long NVDA Daily ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Bank Of Montreal

GraniteShares 1.25x Long Tesla Daily ETF

Direxion Daily S&P Biotech Bear 3X ETF

ProShares UltraShort Silver

Direxion Daily FTSE China Bull 3X ETF

GraniteShares 1.5x Long Coinbase Daily ETF

ProShares Ultra Bloomberg Natural Gas

T-REX 2X Inverse Tesla Daily Target ETF

Volatility Shares Trust 2x Ether ETF

MicroSectors Gold Miners 3X Leveraged ETN

ProShares Ultra Silver

Direxion Daily S&P Biotech Bull 3X ETF

United States Natural Gas

Direxion Daily Gold Miners Bull 3X ETF

iShares Ethereum Trust ETF

iShares US Home Construction

Incannex Healthcare Limited American Depositary Shares

Innovative Eyewear Inc. Common Stock

Septerna Inc. Common Stock

HWH International Inc. Common Stock

DevvStream Corp. Common Stock

Rigetti Computing Inc. Common Stock

ZK International Group Co. Ltd Ordinary Share

Super Micro Computer Inc. Common Stock

Oklo Inc.

CoreWeave Inc. Class A Common Stock

Inno Holdings Inc. Common Stock

Gryphon Digital Mining Inc Common Stock

Next Technology Holding Inc. Ordinary Shares

Kindly MD Inc. Common Stock

Nuvve Holding Corp. Common Stock

Classover Holdings Inc. Class B Common Stock

Oriental Rise Holdings Limited Ordinary Shares

Hyperscale Data Inc. Common Stock

MicroAlgo Inc. Ordinary Shares

AgriFORCE  Growing Systems Ltd. Common Shares

Click here to get full coverage on Aurinia Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - simplywall.st

Aurinia Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations  simplywall.st

Aurinia Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Reports Strong Q1 Earnings Beat - GuruFocus

Aurinia Pharmaceuticals (AUPH) Reports Strong Q1 Earnings Beat  GuruFocus

Aurinia Pharmaceuticals (AUPH) Reports Strong Q1 Earnings Beat - GuruFocus

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth (NASDAQ:AUPH) - Seeking Alpha

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth (NASDAQ:AUPH)  Seeking Alpha

Aurinia Pharmaceuticals: Shareholder Pressure And Sales Growth (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript - Insider Monkey

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript  Insider Monkey

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Aurinia: Q1 Earnings Snapshot - The Washington Post

Aurinia: Q1 Earnings Snapshot  The Washington Post

Aurinia: Q1 Earnings Snapshot - The Washington Post

Click here to get full coverage on Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress - Business Wire

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress  Business Wire

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress - Business Wire

Click here to get full coverage on Aurinia: Q1 Earnings Snapshot - MySA

Aurinia: Q1 Earnings Snapshot - MySA

Click here to get full coverage on Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance - Benzinga

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance  Benzinga

Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance - Benzinga

Click here to get full coverage on Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q1 EPS $0.16, vs. FactSet Est of $0.14 - marketscreener.com

Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q1 EPS $0.16, vs. FactSet Est of $0.14  marketscreener.com

Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q1 EPS $0.16, vs. FactSet Est of $0.14 - marketscreener.com

Click here to get full coverage on Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings May Just Be The Starting Point - Yahoo Finance

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings May Just Be The Starting Point  Yahoo Finance

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings May Just Be The Starting Point - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year - simplywall.st

Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year  simplywall.st

Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) CEO Will Probably Find It Hard To See A Huge Raise This Year - simplywall.st

Click here to get full coverage on Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In - GuruFocus

Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In  GuruFocus

Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In - GuruFocus

Click here to get full coverage on Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting - Business Wire

Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting  Business Wire

Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting - Business Wire

Click here to get full coverage on Aurinia Pharmaceuticals: There's Still Time For Sales Growth (NASDAQ:AUPH) - Seeking Alpha

Aurinia Pharmaceuticals: There's Still Time For Sales Growth (NASDAQ:AUPH)  Seeking Alpha

Aurinia Pharmaceuticals: There's Still Time For Sales Growth (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March - Yahoo Finance

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March  Yahoo Finance

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March - Yahoo Finance

Click here to get full coverage on AUPH Reports Q1 Revenue Exceeding Expectations with Strong Outlo - GuruFocus

AUPH Reports Q1 Revenue Exceeding Expectations with Strong Outlo  GuruFocus

AUPH Reports Q1 Revenue Exceeding Expectations with Strong Outlo - GuruFocus

Click here to get full coverage on Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now? - Yahoo Finance

Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now?  Yahoo Finance

Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now? - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates  Yahoo Finance

Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025 - Business Wire

Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025  Business Wire

Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025 - Business Wire

Click here to get full coverage on LAWSUITS FILED AGAINST AUPH, AXSM and TDOC - Jakubowitz Law Pursues Shareholders Claims - ACCESS Newswire

LAWSUITS FILED AGAINST AUPH, AXSM and TDOC - Jakubowitz Law Pursues Shareholders Claims  ACCESS Newswire

LAWSUITS FILED AGAINST AUPH, AXSM and TDOC - Jakubowitz Law Pursues Shareholders Claims - ACCESS Newswire

Click here to get full coverage on Little Excitement Around Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Revenues - simplywall.st

Little Excitement Around Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Revenues  simplywall.st

Little Excitement Around Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Revenues - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

Aurinia Pharmaceuticals Q1 2025 Earnings Call Transcript  MarketBeat

Aurinia Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

Click here to get full coverage on Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options - Yahoo Finance

Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options  Yahoo Finance

Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options - Yahoo Finance

Click here to get full coverage on Aurinia (AUPH) Upgraded to Buy: Here's Why - Yahoo Finance

Aurinia (AUPH) Upgraded to Buy: Here's Why  Yahoo Finance

Aurinia (AUPH) Upgraded to Buy: Here's Why - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView

Aurinia Pharmaceuticals Inc. SEC 10-Q Report  TradingView

Aurinia Pharmaceuticals Inc. SEC 10-Q Report - TradingView

Click here to get full coverage on Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting - Business Wire

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting  Business Wire

Glass Lewis Recommends That Aurinia Shareholders Vote “FOR” All Proposals at 2025 Annual General Meeting - Business Wire

Click here to get full coverage on We Might See A Profit From Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Soon - simplywall.st

We Might See A Profit From Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Soon  simplywall.st

We Might See A Profit From Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Soon - simplywall.st

Click here to get full coverage on Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon (NASDAQ:AUPH) - Seeking Alpha

Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon (NASDAQ:AUPH)  Seeking Alpha

Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon (NASDAQ:AUPH) - Seeking Alpha

Click here to get full coverage on retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week - simplywall.st

retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week  simplywall.st

retail investors who own 52% along with institutions invested in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) saw increase in their holdings value last week - simplywall.st

Click here to get full coverage on 5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms - Yahoo Finance

5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms  Yahoo Finance

5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms - Yahoo Finance

Click here to get full coverage on Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results - TipRanks

Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results  TipRanks

Aurinia Pharmaceuticals Reports Strong First Quarter 2025 Financial Results - TipRanks

Click here to get full coverage on How the (AUPH) price action is used to our Advantage - news.stocktradersdaily.com

How the (AUPH) price action is used to our Advantage  news.stocktradersdaily.com

How the (AUPH) price action is used to our Advantage - news.stocktradersdaily.com

Click here to get full coverage on Aurinia Pharmaceuticals Reports Strong Q1 2025 Financial Results and Positive Outlook - TipRanks

Aurinia Pharmaceuticals Reports Strong Q1 2025 Financial Results and Positive Outlook  TipRanks

Aurinia Pharmaceuticals Reports Strong Q1 2025 Financial Results and Positive Outlook - TipRanks

Click here to get full coverage on Leerink maintains Aurinia stock Outperform with $10 target - Investing.com

Leerink maintains Aurinia stock Outperform with $10 target  Investing.com

Leerink maintains Aurinia stock Outperform with $10 target - Investing.com

Click here to get full coverage on Aurinia Pharmaceuticals (AUPH) Gains Support from ISS for Board - GuruFocus

Aurinia Pharmaceuticals (AUPH) Gains Support from ISS for Board  GuruFocus

Aurinia Pharmaceuticals (AUPH) Gains Support from ISS for Board - GuruFocus

Click here to get full coverage on Aurinia Pharma earnings beat by $0.05, revenue fell short of estimates - Investing.com

Aurinia Pharma earnings beat by $0.05, revenue fell short of estimates  Investing.com

Aurinia Pharma earnings beat by $0.05, revenue fell short of estimates - Investing.com

Click here to get full coverage on Aurinia Pharma earnings beat by $0.05, revenue fell short of estimates - Investing.com Nigeria

Aurinia Pharma earnings beat by $0.05, revenue fell short of estimates  Investing.com Nigeria

Aurinia Pharma earnings beat by $0.05, revenue fell short of estimates - Investing.com Nigeria

Click here to get full coverage on Aurinia Pharmaceuticals Earns Relative Strength Rating Upgrade - Investor's Business Daily

Aurinia Pharmaceuticals Earns Relative Strength Rating Upgrade  Investor's Business Daily

Aurinia Pharmaceuticals Earns Relative Strength Rating Upgrade - Investor's Business Daily

Click here to get full coverage on Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance

Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates  Yahoo Finance

Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance

Click here to get full coverage on Aurinia Announces Board Restructuring - Business Wire

Aurinia Announces Board Restructuring  Business Wire

Aurinia Announces Board Restructuring - Business Wire

Click here to get full coverage on Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development - Business Wire

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development  Business Wire

Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Development - Business Wire

Click here to get full coverage on Aurinia: Q1 Earnings Snapshot - marketscreener.com

Aurinia: Q1 Earnings Snapshot  marketscreener.com

Aurinia: Q1 Earnings Snapshot - marketscreener.com

Click here to get full coverage on Aurinia Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Aurinia Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations  Yahoo Finance

Aurinia Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Click here to get full coverage on Leerink maintains Aurinia stock Outperform with $10 target By Investing.com - Investing.com Nigeria

Leerink maintains Aurinia stock Outperform with $10 target By Investing.com  Investing.com Nigeria

Leerink maintains Aurinia stock Outperform with $10 target By Investing.com - Investing.com Nigeria

Click here to get full coverage on Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial - Business Wire

Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial  Business Wire

Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial - Business Wire

Click here to get full coverage on 10 Best Small-Cap Growth Stocks to Buy Now - Insider Monkey

10 Best Small-Cap Growth Stocks to Buy Now  Insider Monkey

10 Best Small-Cap Growth Stocks to Buy Now - Insider Monkey

Click here to get full coverage on Kevin Tang buys $10.82 million in Aurinia Pharmaceuticals shares - Investing.com

Kevin Tang buys $10.82 million in Aurinia Pharmaceuticals shares  Investing.com

Kevin Tang buys $10.82 million in Aurinia Pharmaceuticals shares - Investing.com

Click here to get full coverage on Aurinia Pharmaceuticals to Announce Q1 2025 Results - TipRanks

Aurinia Pharmaceuticals to Announce Q1 2025 Results  TipRanks

Aurinia Pharmaceuticals to Announce Q1 2025 Results - TipRanks

Click here to get full coverage on Aurinia Pharmaceuticals’ chief medical officer sells $97,912 in stock - Investing.com

Aurinia Pharmaceuticals’ chief medical officer sells $97,912 in stock  Investing.com

Aurinia Pharmaceuticals’ chief medical officer sells $97,912 in stock - Investing.com

Click here to get full coverage on Aurinia Pharmaceuticals CFO Joseph Miller sells shares worth $939,611 - Investing.com

Aurinia Pharmaceuticals CFO Joseph Miller sells shares worth $939,611  Investing.com

Aurinia Pharmaceuticals CFO Joseph Miller sells shares worth $939,611 - Investing.com

Click here to get full coverage on Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024 - Business Wire

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024  Business Wire

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS® in Managing LN at American College of Rheumatology Convergence 2024 - Business Wire

Click here to get full coverage on ISS Endorses Aurinia’s Proposals for 2025 Annual Meeting - TipRanks

ISS Endorses Aurinia’s Proposals for 2025 Annual Meeting  TipRanks

ISS Endorses Aurinia’s Proposals for 2025 Annual Meeting - TipRanks

Click here to get full coverage on Aurinia Pharmaceuticals Reports Strong Financial Growth in 2024 - TipRanks

Aurinia Pharmaceuticals Reports Strong Financial Growth in 2024  TipRanks

Aurinia Pharmaceuticals Inc (AUPH)

Price Chart

Key Statistics

Technicals

About AUPH

Latest News

Aurinia Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - simplywall.st

Aurinia Pharmaceuticals (AUPH) Reports Strong Q1 Earnings Beat - GuruFocus

Aurinia Pharmaceuticals (AUPH) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers